{
  "id": "2fc78ef03032beb9",
  "title": "Eli Lilly Builds $1 . 5 Billion Inventory Of Experimental Weight - Loss Pill As FDA Decision Looms - Eli Lilly and Co ( NYSE : LLY ), Novo Nordisk ( NYSE : NVO ) ",
  "description": "20260213T110000Z",
  "content": "",
  "source": "benzinga.com",
  "source_url": "https://www.benzinga.com/news/health-care/26/02/50604054/eli-lilly-builds-1-5-billion-inventory-of-experimental-weight-loss-pill-as-fda-decision-looms",
  "published_at": "20260213T110000Z",
  "fetched_at": "2026-02-14T00:29:18.398832+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.benzinga.com/news/health-care/26/02/50604054/eli-lilly-builds-1-5-billion-inventory-of-experimental-weight-loss-pill-as-fda-decision-looms",
    "url_mobile": "",
    "title": "Eli Lilly Builds $1 . 5 Billion Inventory Of Experimental Weight - Loss Pill As FDA Decision Looms - Eli Lilly and Co ( NYSE : LLY ), Novo Nordisk ( NYSE : NVO ) ",
    "seendate": "20260213T110000Z",
    "socialimage": "https://cdn.benzinga.com/files/images/story/2026/02/13/Los-Angeles--California---July-7-2025-El.jpeg?&fit=crop",
    "domain": "benzinga.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}